Subsequently, we drew a nomogram consisting HTN3, IL3RA and NCK1 to quantitatively predict 1-, 2- and 3-year OS in CLL patients (Fig. 2D). This evidence concerns the gene IL3RA and B-cell chronic lymphocytic leukemia.